Cary Street Partners Investment Advisory’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-1,759
Closed -$223K – 688
2025
Q3
$223K Sell
1,759
-29
-2% -$3.45K 0.09% 243
2025
Q2
$219K Buy
+1,788
New +$204K 0.11% 218
2023
Q4
– Sell
-537
Closed -$36.1K – 934
2023
Q3
$36.1K Hold
537
– – ﹤0.01% 954
2023
Q2
$36.4K Buy
+537
New +$33.7K ﹤0.01% 897

Other funds holding EHC

Cary Street Partners Investment Advisory's EHC Position: Q4 2025 in Review

Cary Street Partners Investment Advisory sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,759 shares — an estimated $223K sold.

Cary Street Partners Investment Advisory first reported a position in EHC in Q2 2023 and held it in 4 quarters. The position peaked at $223K in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Cary Street Partners Investment Advisory reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 1,759 Encompass Health shares in Q4 2025, an estimated $223K.
  • Cary Street Partners Investment Advisory first reported a position in Encompass Health in Q2 2023 and held it in 4 quarters.
  • Cary Street Partners Investment Advisory's Encompass Health position peaked at $223K in Q3 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2025, filed 9 Feb 2026.